Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734117 · ClinicalTrials.gov registry record
A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome
A clinical trial, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 5,429
- Enrollment target
NCT06734117 is a clinical trial that has completed, run by Hoffmann-La Roche. The registered enrollment target is 5,429 participants.
The verdict
NCT06734117 has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 5,429 participants
- Enrollment target
Study Summary
This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.
Interventions
- PROCEDURE Blood sample collection
- DIAGNOSTIC_TEST Elecsys® Troponin T hs Gen 6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,429 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2024-12-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06734117
The ClinicalTrials.gov registry entry for NCT06734117 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,429 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sample collection is the first listed.
NCT06734117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06734117 about?
NCT06734117 is a clinical study titled "A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome". This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the stu...
What is the current status of trial NCT06734117?
This trial is currently completed. The enrollment target is 5,429 participants. The study started on 2021-11-15. Estimated completion is 2024-12-26.
What interventions are being tested in trial NCT06734117?
The interventions under investigation include: Blood sample collection (PROCEDURE), Elecsys® Troponin T hs Gen 6 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06734117?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.